The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract
Phase 1
Completed
- Conditions
- Age Related Cataracts
- Interventions
- Drug: Saline Solution (Placebo)
- First Posted Date
- 2024-04-15
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- Livionex Inc.
- Target Recruit Count
- 111
- Registration Number
- NCT06365762
- Locations
- 🇺🇸
Hunkeler Eye Institute, Overland Park, Kansas, United States
🇺🇸St Mary's Eye Specialists, Inc., San Francisco, California, United States
🇺🇸The Johns Hopkins Hospital & Health System, Wilmer Eye Institute, Lutherville, Maryland, United States
© Copyright 2025. All Rights Reserved by MedPath